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The BLOC-3 subunit HPS4 is required for activation of
Rab32/38 GTPases in melanogenesis, but its Rab9 activity is
dispensable for melanogenesis
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HPS4 biogenesis of lysosome-related organelles complex 3 sub-
unit 2 (HPS4) is one of the genes whose mutations have been
associated with Hermansky–Pudlak syndrome (HPS), charac-
terized by ocular albinism and susceptibility to bleeding because
of defects in the biogenesis of lysosome-related organelles such
as melanosomes. HPS4 protein forms a BLOC-3 complex with
HPS1, another HPS gene product, and the complex has been
proposed to function as a guanine nucleotide exchange factor
(GEF) for RAB32, a member of the Rab small GTPase family
(Rab32), and Rab38 (Rab32/38-GEF) and also as a Rab9 effec-
tor. Although both Rab32/38 and Rab9 have been shown pre-
viously to be involved in melanogenesis in mammalian epi-
dermal melanocytes, the functional relationships of these
small GTPases with BLOC-3 remain unknown. In this study,
we used site-directed mutagenesis to generate HPS4 mutants
that specifically lack either Rab32/38-GEF activity or Rab9-
binding activity and investigated their involvement in mela-
nogenesis of melan-le cells (an HPS4-deficient melanocyte
cell line derived from light ear mice). Melan-le cells exhibit a
clear hypopigmentation phenotype, i.e. reduced expression
and abnormal distribution of tyrosinase and reduced melanin
content. Although re-expression of WT HPS4 completely
rescued this phenotype, the Rab32/38-GEF activity– deficient
HPS4 mutant failed to restore melanin content and tyrosinase
trafficking in these cells. Unexpectedly, as WT HPS4, the Rab9
binding– deficient HPS4 mutant completely rescued the pheno-
type. These results indicate that activation of Rab32/38 by HPS4
(or BLOC-3) is essential for melanogenesis of cultured melano-
cytes and that Rab9 likely regulates melanogenesis indepen-
dently of HPS4.
Hermansky–Pudlak syndrome (HPS)4 is a rare autosomal
recessive disorder characterized by defects in the biogenesis of
lysosome-related organelles (LROs) that have several features
in common with lysosomes; however, LROs such as the mela-
nosomes in melanocytes and dense granules in platelets have
other specific characteristics of their own (reviewed in Ref. 1).
Previous studies have identified 10 genetic loci associated with
HPS (2). With the exception of the gene encoding a subunit of
AP-3 (HPS2), HPS-related gene products form three different
complexes, called biogenesis of lysosome-related organelles
complex (BLOC) 1 to 3, and play pivotal roles in trafficking and
sorting LRO-specific cargoes (3).
Melanosomes are representative LROs that synthesize and
store melanin pigments in epidermal melanocytes (hereafter
simply called melanocytes). Because melanosomes are rela-
tively large (500 nm) and contain dark pigment, they are easily
observed even under a light microscope (4). Furthermore,
because many types of melanocytes that exhibit defects in mela-
nosome biogenesis or transport have been isolated from coat
color–mutant mice, studies of the melanosomes of these
mutant melanocytes have provided information that is helpful
for understanding the molecular mechanism of LRO biogenesis
and transport (5, 6).
Rab small GTPases are well-known regulators of membrane
trafficking in eukaryotic cells. Approximately 60 Rab members
are present in mammals, and each Rab localizes at distinct
organelles (or subcellular compartments), where it regulates
their trafficking (7–9). Like other small GTPases, the cycling of
Rab proteins between a GTP-bound active form and a GDP-
bound inactive form is regulated by guanine nucleotide ex-
change factors (GEFs) and GTPase-activating proteins (GAPs)
(10 –12). Various Rab proteins have been suggested to regulate
melanosome biogenesis and transport in melanocytes (13). One
of them, Rab38, whose function is impaired in chocolate mice
(a mouse model of HPS) (14), and its paralog, Rab32, have been
shown to regulate the trafficking of melanogenic enzymes (e.g.
tyrosinase and tyrosinase-related protein 1) from the trans-
Golgi network and/or endosomes to melanosomes (15).
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BLOC-3, a heterodimeric complex of HPS1 and HPS4, has
recently been reported to be a specific GEF for Rab32 and
Rab38 (Rab32/38) (16). Interestingly, BLOC-3 has also been
reported to be a Rab9 effector (17), and involvement of Rab9A
in melanogenesis has been reported by two independent groups
(18, 19). Based on these findings, Rab9A and Rab32/38 have
been proposed to constitute a Rab cascade through BLOC-3 in
melanogenesis (11, 16, 18, 20), the same as Rab5 and Rab7,
which constitute a Rab cascade through Mon1-Ccz1 in endo-
some maturation (21). However, whether the BLOC-3–
mediated Rab cascade actually functions in melanocytes has
never been experimentally investigated.
To clarify the functional relationship between HPS4 and
these Rabs, in this study we performed rescue experiments by
using genetically HPS4-deficient melanocytes (i.e. melan-le
cells, which have reduced melanin content and a defect in tyro-
sinase trafficking) and HPS4 mutants specifically lacking
Rab32/38 activation ability or Rab9A-binding ability. The
results showed that a Rab9 binding– deficient HPS4 mutant
completely restored melanogenesis in melan-le cells but that a
Rab32/38-GEF activity– deficient mutant failed to restore
either melanin content or tyrosinase trafficking. Our findings
indicate that the Rab32/38-GEF function of HPS4 is indepen-
dent of its Rab9A binding, and an alternate role of Rab9A in
melanogenesis is discussed.
Results
HPS4, not HPS1, is an active Rab9-specific binding protein
HPS4, a component of the BLOC-3 complex (simply called
BLOC-3 hereafter), has been shown to directly interact with
Rab9A and Rab9B but not with Rab5A, Rab7, or Rab27A (17).
However, because mammals contain 60 different Rabs, HPS4
may be capable of interacting with other Rabs with higher affin-
ity than with Rab9. To determine the Rab binding specificity of
HPS1 and HPS4, we first performed yeast two-hybrid assays by
using constitutively active (CA) and constitutively negative
(CN) mutants of 62 different mammalian Rabs as bait and HPS1
and HPS4 as prey, as described previously (22–24). The results
of the comprehensive screening showed that HPS4 strongly
interacted with an active form of Rab9A/B (Fig. 1, boxed) con-
sistent with a previous report (17). A negative form of
Rab40B/C appeared to be positive for HPS4, but because of
their relatively weak interactions, we did not pursue them in the
subsequent analysis. By contrast, none of the CA/CN Rabs
interacted with HPS1 (Fig. 1). We therefore concluded that
HPS4, not HPS1, is an active Rab9-specific binding protein.
Mapping of the Rab9-binding domain in HPS4 by truncation
analysis
We next attempted to identify the minimum region of HPS4
that is required for Rab9 binding by performing a systematic
truncation analysis (Fig. 2A). HPS4 contains an N-terminal
longin domain (16), but no known protein motifs are present in
the large C-terminal portion. We therefore prepared five N-ter-
minal truncated mutants (N1–N5) and five C-terminal
truncated mutants (C1–C5) and performed yeast two-hy-
brid assays (Fig. 2A). Interestingly, deletion of either the N-ter-
minal 200 amino acids or the C-terminal 200 amino acids of
HPS4 completely abrogated its Rab9 binding activity (Fig. 2B).
Further truncation analysis indicated that amino acids 150 –
570 of HPS4 (Fig. 2A, dashed box) are necessary and sufficient
for its Rab9 binding activity (Fig. 2C).
Identification of the amino acid residues in HPS4 for Rab9
binding by site-directed mutagenesis
The minimum Rab9-binding domain identified above contains
400 amino acids, and it is clearly larger than the usual Rab-bind-
ing domains (100 amino acids) of the Rab effectors that function
in melanocytes, e.g. the Rab27-binding domain of Slac2-a/melano-
philin, the Rab32/38-binding domain of Varp, and the Rab36-
binding domain of Rab interacting lysosomal protein (RILP) (23,
25, 26). Because these known Rab-binding domains are well con-
served in different species of vertebrates, we compared seven
HPS4 sequences from different vertebrate species: human, bovine,
Figure 1. Rab binding specificity of HPS1 and HPS4. The Rab binding specificity of mouse HPS1 and HPS4 was determined by yeast two-hybrid assays. Yeast
cells containing both pGBD-C1 plasmids, which express a CA form (which mimics the GTP-bound form) or a CN form (which mimics the GDP-bound form) of
mouse or human Rab lacking the C-terminal Cys residues (positions are indicated in the left panel), and pAct2 plasmids, which express mouse HPS1 or HPS4,
were streaked on SC-AHLW (lacking adenine, histidine, leucine, and tryptophan) selection medium and incubated at 30 °C. Note that HPS4 specifically
interacted with the active form of Rab9A and Rab9B (boxed), whereas neither Rab interacted with HPS1.
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rat, mouse, chicken, frog, and fish (Fig. 3A). To our surprise, the
amino acid sequences of the minimal Rab9-binding domain of
HPS4 were not well-conserved in the different vertebrate species
tested. However, we succeeded in identifying two regions of HPS4,
amino acids 150–200 and 520–570, that are highly conserved
between different species. To identify the critical HPS4 residues
for Rab9 binding, we selected eight candidate amino acids from
these two regions, i.e. His-154, Phe-157, Gln-181, Gln-184, Ser-
541, Asn-543, His-548, and Thr-552, and performed Ala-based
site-directed mutagenesis (Fig. 3A, arrowheads). We prepared
four HPS4 mutants (H154A/F157A, Q181A/Q184A, S541A/
N543A, and H548A/T552A) and evaluated their Rab9 binding
ability as described above. As shown in Fig. 3B, only the S541A/
N543A mutations clearly impaired Rab9A/B binding activity,
and the other mutations had no effect. The defective Rab9
binding activity of the HPS4(S541A/N543A) mutant was fur-
ther confirmed by co-immunoprecipitation assays in COS-7
cells (Fig. 4A, compare lanes 1 and 2). In addition, the
HPS4(S541A/N543A) mutant interacted normally with
HPS1 (Fig. 4B, lane 4). These results, taken together, indicate
that the HPS4(S541A/N543A) mutant specifically lacks
Rab9 binding ability without affecting formation of the
BLOC-3 complex (i.e. interaction with HPS1).
G55W/G59M mutations in the longin domain of HPS4
impaired Rab32/38-GEF activity
It has been shown previously that the N-terminal longin
domain of HPS4, which is not required for Rab9 binding (Fig. 2),
is involved in GEF activity toward Rab32/38 (16). To investigate
whether the longin domain and Rab9-binding domain of HPS4
are functionally related, we also attempted to produce its
Rab32/38-GEFactivity– deficientmutantbysite-directedmuta-
genesis. Although nothing is known about the residues of HPS4
that are critical for its Rab32/38-GEF activity, we utilized recent
structural data in regard to the thermophilic fungus Chaeto-
mium thermophilum Ccz1 (27) because Ccz1 contains a similar
longin domain, and Ccz1, together with Mon1, functions as a
heterodimeric GEF for Rab7/Ypt7 (21, 28). Comparison of the
Figure 2. Mapping of the site responsible for Rab9 binding in HPS4. A, schematic of mouse HPS4 and its truncation mutants used in this study. Amino acid
numbers are shown on both sides. HPS4 contains an N-terminal longin domain (i.e. Rab32/38-GEF domain) (16). The Rab9(CA/CN) binding activity of each HPS4
truncation mutant is summarized at the right of each construct. B and C, Rab9 binding activity of HPS4 truncation mutants. Yeast cells containing pGBD-C1-
Rab9A/B(CA/CN)Cys plasmids and pAct2 plasmids expressing HPS4 truncation mutants were streaked on SC-LW (lacking leucine and tryptophan) or SC-
AHLW medium (selection medium) and incubated at 30 °C. Note that amino acids 150 –570 of HPS4 are the minimal Rab9-binding site.
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longin domains of HPS4 and Ccz1 revealed that several amino
acids were highly conserved, and we especially focused on
Gly-55 and Gly-59 of HPS4 (Fig. 5A) because these two Gly
residues are critical for the GEF activity of CtCcz1, and the yeast
Ccz1(G47W/G51M) mutant is unable to rescue a vacuolar frag-
mentation phenotype of ccz1 cells (27). We therefore intro-
duced similar mutations into the longin domain of HPS4
(G55W and G59M) by site-directed mutagenesis (Fig. 5A,
arrowheads). Although the Sec2 and VPS9 GEF domains have
been demonstrated to physically interact with a CN form of
Rabs (mimics their substrates) by conventional yeast two-hy-
brid assays (23, 29, 30), HPS4 alone was unable to interact
with CN-Rab32/38 (Fig. 1). Because heterodimer formation
by HPS1 and HPS4 is required for Rab32/38-GEF activity
(16), both BLOC-3 components would be necessary for
the interaction with CN-Rab32/38. To confirm that they are,
we evaluated the interaction between BLOC-3 and
CN-Rab32/38 or CA-Rab32/38 by performing yeast tri-hy-
brid assays as described under “Experimental procedures.”
As expected, BLOC-3 containing the WT HPS4 specifically
interacted with CN-Rab32/38 but was unable to interact
with CA-Rab32/38 or CA/CN-Rab7 (Fig. 5B, top row). In
contrast, BLOC-3 containing the HPS4(G55W/G59M)
mutant failed to interact with CN-Rab32/38, even in the
presence of HPS1 (Fig. 5B, center row), suggesting that the
HPS4(G55W/G59M) mutant lacks Rab32/38-GEF activity.
Because these two mutations are located in the longin
domain, which, as described above, is not essential for Rab9
binding (Fig. 2), the HPS4(G55W/G59M) mutant interacted
normally with Rab9 (Figs. 4A, lane 3, and 5C) in addition to
HPS1 (Fig. 4B, lane 5). In contrast, the Rab9 binding–
deficient HPS4(S541A/N543A) mutant still interacted with
CN-Rab32/38 in the presence of HPS1 (Fig. 5B, bottom row),
suggesting that this mutant retains Rab32/38-GEF activity.
We therefore concluded that the G55W/G59M and S541A/
N543A mutants of HPS4 would be useful tools for analyzing
the functional relationships between the Rab32/38-GEF
activity and Rab9 binding activity of HPS4 in cultured
melanocytes.
Figure 3. Identification of critical residues responsible for Rab9 binding in HPS4 by site-directed mutagenesis. A, heatmap analysis of conserved
residues of HPS4 from seven vertebrate species: mouse (Mm), human (Hs), rat (Rn), bovine (Bt), chicken (Gg), frog (Xl), and zebrafish (Dr). Conserved residues in
the minimal Rab9-binding site of HPS4 (black background) are shown at the bottom of the heatmap. Eight conserved amino acids were selected and subjected
to Ala-based site-directed mutagenesis (arrowheads). B, Rab9 binding activity of HPS4 point mutants. Yeast cells containing pGBD-C1-Rab9A/B(CA/CN)Cys
plasmids and pAct2 plasmids expressing HPS4 point mutants were streaked on SC-LW or SC-AHLW medium (selection medium) and incubated at 30 °C. Note
that Ser-541 and Asn-543 of HPS4 are crucial for Rab9(CA) binding.
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Rab32/38-GEF activity, not Rab9 binding activity, of HPS4 is
essential for melanogenesis in melanocytes
In the final set of experiments, we investigated whether the
HPS4 mutants described above could support melanogenesis in
melanocytes. To do so, we focused on an HPS4-deficient
immortal melanocyte cell line (melan-le), which was estab-
lished from a light ear mouse (31), and performed rescue exper-
iments by stably expressing WT and mutant HPS4 in melan-le
cells by retrovirus infection. Because of the absence of func-
tional HPS4 protein in melan-le cells, melan-le cells should
contain a reduced amount of active Rab32/38. To confirm this,
we first observed the intracellular localization of endogenous
Rab32 by performing an immunofluorescence analysis (Fig.
6A). We did not test Rab38 because Rab32 and Rab38 have been
shown to be functionally redundant in melanocytes (15, 18, 32)
and because our anti-Rab38 antibody does not function well in
immunofluorescence analyses. As expected, re-expression of
HPS4 with an HA tag in melan-le cells restored the perinuclear
punctate localization of Rab32 (Fig. 6A, bottom left), whereas
hardly any Rab32 signals were observed in control melan-le
cells (Fig. 6A, top left), presumably because inactive Rab32 is
mostly present in the cytosol. It should be noted that the GEF
activity– deficient HPS4(G55W/G59M) mutant failed to re-
store punctate localization of Rab32 (Fig. 6A, bottom right).
Unexpectedly, however, the Rab9 binding activity– deficient
HPS4(S541A/N543A) mutant fully restored Rab32 localization
(Fig. 6A, top right), suggesting that Rab32 is correctly activated
and localized at the proper sites in HPS4(S541A/N543A)-re-
expressing cells. To validate the immunofluorescence data, we
performed GTP-Rab32 pulldown assays using the GTP-Rab32-
binding domain of Varp (RBD32), as described previously (18),
to check the activation status of Rab32 in WT and mutant
HPS4-expressing cells. Although hardly any active Rab32 was
trapped by the RBD32 beads in control melan-le cells (Fig. 6B,
lane 1), re-expression of HPS4(WT) in melan-le cells clearly
increased the active Rab32 level (Fig. 6B, lane 2). Similarly, re-
expression of the HPS4(S541A/N543A) mutant in melan-le
cells also increased the active Rab32 level (Fig. 6B, lane 3), and no
apparent difference in the amount of GTP-Rab32 was observed
between HPS4(S541A/N543A)- and HPS4(WT)-expressing cells.
In contrast, the GEF activity–deficient HPS4(G55W/G59M)
mutant was unable to increase the GTP-Rab32 level (Fig. 6B, lane
4). These results, taken together, indicated that the HPS4(S541A/
N543A) mutant can normally activate Rab32 (and presumably
Rab38) in melan-le cells, the same as WT HPS4, and thus it is
possible that the activation of Rab32/38 by HPS4 occurs indepen-
dently of Rab9. To further investigate this possibility, we evaluated
the effect of Rab9A knockdown on the active Rab32 level in black
mouse–derived melan-a cells (33). Rab9B knockdown was not
performed because we showed previously that Rab9B is not
expressed in melan-a cells (18). The results showed that neither
Rab32 punctate localization nor the GTP-Rab32 level were
affected in Rab9A-knockdown cells compared with control cells
(Fig. 7, A and B). However, because Rab32 signals were mildly
decreased in Rab9A knockdown cells, Rab9A may partly be
involved in endosomal localization of Rab32 independent of HPS4
(Fig. 7A).
Because Rab32/38, targets of BLOC-3, are known to regulate
the trafficking of melanogenic enzymes to melanosomes (15,
18, 23, 32, 34, 35), we investigated the impact of the two HPS4
mutants on tyrosinase trafficking and melanin synthesis in
melan-le cells. In control melan-le cells, tyrosinase signals were
restricted to the perinuclear region (Fig. 8A, top left panel,
arrow), and hardly any black melanosomes were observed (Fig.
8A, top right panel). Re-expression of HPS4(WT) clearly
restored the peripheral distribution of tyrosinase (Fig. 8A, sec-
ond left panel), and black-pigmented melanosomes were
restored (Fig. 8A, second right panel). The increased tyrosinase
protein level and melanin content were also confirmed by
immunoblotting (Fig. 8, B and C) and by measuring optical
density at 490 nm (Fig. 8, D and E), respectively. Re-expression
of the Rab9 binding activity– deficient HPS4(S541A/N543A)
mutant restored the peripheral distribution of tyrosinase and
melanin content to the same level as in HPS4(WT)-expressing
Figure 4. Rab9 or HPS1 binding activity of HPS4(WT and mutants) in
mammalian cultured cells. A, Rab9A binding activity of HPS4(WT and
mutants) in the presence of 0.5 mM GTPS. IB, immunoblot; IP, immunopre-
cipitation. B, normal HPS1 binding activity of HPS4 mutants. The interaction
between T7-tagged HPS4(WT or mutants) and FLAG-tagged Rab9A (in A) or
HPS1 (in B) was analyzed by co-immunoprecipitation assays in COS-7 cells
with anti-FLAG tag antibody– conjugated agarose beads. Co-immunopre-
cipitated T7-HPS4 and immunoprecipitated FLAG-Rab9A or FLAG-HPS1 were
detected by immunoblotting with anti-T7 tag antibody and anti-FLAG tag
antibody, respectively. The positions of the molecular mass markers (in kilo-
daltons) are shown on the left. Note that HPS4(SA/NA) specifically lacks Rab9A
binding ability, consistent with the results of the yeast two-hybrid assays
shown in Fig. 3, but that there is no change in HPS1 binding ability. SA/NA,
S541A/N543A; GW/GM, G55W/G59M.
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cells, whereas re-expression of the GEF activity– deficient
HPS4(G55W/G59M) did not (Fig. 8, A–E). We therefore con-
cluded that the Rab32/38-GEF activity of HPS4 is necessary and
sufficient for trafficking of tyrosinase to melanosomes and mel-
anin synthesis in melanocytes and that the function of HPS4 is
independent of Rab9, even though Rab9 itself is required for
tyrosinase trafficking and melanin synthesis, as reported previ-
ously (18, 19).
Figure 5. Identification of critical residues responsible for the Rab32/38-GEF activity of HPS4 by site-directed mutagenesis. A, sequence alignment of
the longin domain of mouse (Mm), human (Hs), and rat (Rn) HPS4 and yeast Ccz1. Identical residues and conserved residues in HPS4 are shown against a black
background and gray background, respectively. Two Gly residues, Gly-47 and Gly-51, in yeast Ccz1 have been shown to be essential for Ypt7-GEF activity (27),
and the corresponding Gly residues were also conserved in mammalian HPS4 and were the focus of the site-directed mutagenesis to create Rab32/38-GEF
activity– deficient HPS4. B, Rab32/38(CA/CN) binding activity of BLOC-3 (HPS1/4) WT and mutants as revealed by yeast tri-hybrid assays. Yeast cells containing
pHPS1 plasmids, pAct2 plasmids expressing HPS4(WT or mutants), and pGBD-C1-Rab7/32/38(CA/CN)Cys plasmids were streaked on SC-LWU (lacking leucine,
tryptophan, and uracil) or SC-AHLWU (lacking adenine, histidine, leucine, tryptophan, and uracil) medium (selection medium) and incubated at 30 °C. C, the
normal Rab9 binding activity of HPS4(G55W/G59M) (GW/GM). Two-hybrid assays were performed as described for Fig. 3B.
Figure 6. Effect of HPS4 mutants on localization and activation of Rab32 in melan-le cells. A, stable expression of the Rab9 binding– deficient HPS4 mutant
(S541A/N543A (SA/NA)), not of the Rab32/38-GEF activity– deficient mutant (G55W/G59M (GW/GM)), restored clear punctate localization of Rab32 in melan-le
cells, the same as HPS4(WT) did. HA-tagged HPS4(WT, S541A/N543A, or G55W/G59M) was stably expressed in melan-le cells by retrovirus infection followed by
puromycin selection. Immunostained Rab32 was analyzed with a confocal fluorescence microscope. Cells that did not contain clear Rab32 puncta are outlined
with a broken line. Expression of HPS4(WT or SA/NA) in melan-le cells significantly increased Rab32 signals compared with control melan-le cells (melan-le,
1.00  0.0643 (means  S.E., relative intensity); melan-le  HPS4(WT), 2.33  0.110; melan-le  HPS4(SA/NA), 2.01  0.123; p  0.01, Tukey’s test), whereas
expression of HPS4(GW/GM) in melan-le cells had no significant effect (1.06  0.0823). Scale bar  20 m. B, the level of GTP-Rab32 in melan-le cells stably
expressing HPS4(WT and mutants). Active Rab32 pulldown assays were performed as described under “Experimental procedures” (18). In brief, GSH-Sepharose
beads coupled with T7-GST-RBD32 were incubated with a lysate of melan-le cells expressing HPS4(WT or mutants). Proteins bound to the beads were analyzed
by immunoblotting with anti-Rab32 antibody (top panels) and anti-HA tag antibody (bottom panels) or by Amido Black staining for T7-GST-RBD32. The amount
of endogenous Rab32 in the reaction mixture was adjusted before incubation with the beads (i.e. lysates for HPS4(WT) and HPS4(SA/NA) were diluted twice
with the binding buffer). The positions of the molecular mass markers (in kilodaltons) are shown on the left. Note that HPS4(SA/NA) activated Rab32 in melan-e
cells, the same as HPS4(WT) did, but HPS4(GW/GM) did not.
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Rab32/38 and Rab9 have been reported to be involved in
melanogenesis (15, 18, 19), but whether these small GTPases
regulate the trafficking of melanogenic enzymes synergistically
or independently has remained unknown. Recent identification
of BLOC-3 as a Rab32/38-GEF (16) and HPS4 as a Rab9 effector
(17) prompted many researchers, including us, to hypothesize
that HPS4 serves as a functional link between Rab32/38 and
Rab9 during melanogenic enzyme trafficking; that is, that
Rab9 –BLOC-3–Rab32/38 constitutes a cascade in which Rab9
recruits BLOC-3 to an organelle membrane, where it then acti-
vates Rab32/38 (11, 16, 18, 20). In this study, we tested this
hypothesis by evaluating the functional relationship between
Rab32/38 and Rab9 by preparing Rab32/38-GEF activity–
deficient and Rab9 binding activity– deficient HPS4 mutants
(Figs. 3, 4, and 5) and then performing rescue experiments using
HPS4-deficient melan-le cells and these HPS4 mutants. The
results, however, showed that the activation, localization, and
function of Rab32/38 in melanogenesis entirely depend on the
Rab32/38-GEF activity of BLOC-3 and are mostly independent
of Rab9A (Figs. 6, 7, and 8). Thus, Rab32/38 and Rab9 are likely
to contribute independently to melanogenesis in melanocytes.
Although the BLOC-3–mediated Rab cascade model de-
scribed above is a fascinating model, the results of our study
clearly demonstrated that Rab9 is dispensable for activation
and localization of Rab32/38, at least in melanocytes. How,
then, is Rab9 involved in melanin synthesis? Because Rab9 is
thought to regulate endosome–to–trans-Golgi network trans-
port (36, 37), and various molecules other than melanogenic
enzymes, e.g. transporters and the fibril protein premelano-
some protein (PMEL), need to be transported to immature
melanosomes for maturation (5, 6), Rab9 may be involved in the
transport or recycling of these molecules during melanogene-
sis, and that may indirectly affect the levels of melanogenic
enzyme expression. Alternatively, Rab9 may bind to the Rab32/
38-GAP RUTBC1 and regulate Rab32/38 recycling or localiza-
tion (18). Actually, because the Rab32 signals were mildly
affected in Rab9A knockdown cells (Fig. 7), Rab9 binding activ-
ity of RUTBC1 may be involved in localization of Rab32/38.
Further analysis of a Rab9 binding– deficient RUTBC1 mutant
in RUTBC1 knockdown/knockout cells will be necessary to
resolve this issue.
Although the BLOC-3–mediated Rab cascade is highly
unlikely to function during melanogenesis in melanocytes, the
cascade may still play an important role in other types of mem-
brane trafficking in different cell types. Actually, Rab32/38 have
been reported to regulate the biogenesis of other lysosome-
related organelles and to prevent pathogenic microbial infec-
tions (38). We have especially noted the latter function of
Rab32/38 because they localize to bacterial pathogen–
containing endosomes, and BLOC-3 has been shown to be
required for this process (39 –42). It will be interesting to inves-
tigate whether the BLOC-3–mediated Rab cascade is involved
in defense against pathogenic microbial infections. A Rab9
binding– defective HPS4 mutant we developed in this study will
be a useful tool for evaluating the importance of the BLOC-3–
mediated Rab cascade during microbial infection.
It is now widely thought that Rab-GEFs are major determi-
nants of Rab membrane localization (43). Our findings support
this thinking because Rab32/38 did not show any clear mem-
branous localizations in the absence of BLOC-3 GEF activity
(Fig. 6). However, immunofluorescence analysis revealed
hardly any colocalization of HA-tagged HPS4 with Rab32/38 in
rescued melan-le cells; instead, it was mostly localized in the
cytoplasm (data not shown). We therefore speculate that
another binding partner of BLOC-3 is required for its transient
localization at immature melanosomes or endosomes. Alterna-
tively, Rab32/38 themselves may contain targeting sequences,
e.g. a hypervariable C-terminal domain, that target them to spe-
cific organelles (44). Further extensive research will be neces-
sary to determine the precise molecular mechanism by which
BLOC-3 defines the site of Rab32/38 activation.
In summary, we have identified the critical amino acids
responsible for the Rab32/38-GEF activity and Rab9 binding
activity of HPS4 and have demonstrated, by means of loss-of-
function HPS4 mutants, that BLOC-3–GEF activity toward
Rab32/38 is essential for melanogenesis in melanocytes, and
that Rab9 binding activity is not. In the future, the HPS4
mutants developed in this study will be useful for analyzing
other BLOC-3–mediated membrane trafficking events, such as
defense against pathogenic microbial infection.
Figure 7. Effect of Rab9A knockdown on localization and activation of
endogenous Rab32 in melan-a cells. A, localization of endogenous Rab32 in
Rab9A knockdown melan-a cells. Melan-a cells were transfected with siRNAs
against Rab9A and then immunostained with anti-Rab32 antibody. Although
no apparent change in punctate localization of Rab32 was observed in
Rab9A-knockdown cells, their Rab32 signals were mildly but significantly
reduced compared with control melan-a cells (siControl, 1.00  0.0819
(means  S.E., relative intensity); siRab9A#1, 0.556  0.0495; and siRab9A#2,
0.679  0.0559; **, p  0.01, Dunnet’s test). Scale bars  20 m. B, the same
level of active Rab32 between control cells and Rab9 knockdown melan-a
cells. Active Rab32 pulldown assays were performed as described under
“Experimental procedures” (18), and the description of the immunoblot data
is the same as for Fig. 6B. The positions of the molecular mass markers (in
kilodaltons) are shown on the left.
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The following antibodies used in this study were obtained
commercially: horseradish peroxidase– conjugated anti-T7 tag
mouse mAb (NovagenTM, Merck, Darmstadt, Germany),
horseradish peroxidase– conjugated anti-FLAG tag mouse
monoclonal (M2) antibody and anti-FLAG tag antibody–
conjugated agarose beads (Sigma-Aldrich), anti-HA tag rat
monoclonal (3F10) antibody (Roche, Rotkreuz, Switzerland),
anti--actin mouse mAb (Applied Biological Materials, Rich-
mond, British Columbia, Canada), and Alexa Fluor 488 –
conjugated anti-rabbit IgG goat antibody (Thermo Fisher Sci-
entific, Waltham, MA). Rabbit polyclonal antibodies against
Rab32, Rab9A, and tyrosinase were prepared as described pre-
viously (18, 23). GSH-Sepharose beads were purchased from
GE Healthcare. siRNAs against mouse Rab9A (target site 1,
5-CAAGACUGACAUAAAAGAATT-3; target site 2, 5-GGA-
GGCAGUUCGAAGAAUUTT-3) were chemically synthesized
by Nippon Gene (Toyama, Japan).
Plasmid construction and site-directed mutagenesis
cDNA encoding the ORF of mouse HPS1 was amplified from
Marathon-Ready adult mouse brain and testis cDNAs (Clon-
tech/Takara Bio, Shiga, Japan) by PCR using the following spe-
cific primers containing a BamHI linker (underlined) or a stop
codon (bold): HPS1 Met primer, 5-GGATCCATGAAGTGC-
GTGTTGGTGGC-3; HPS1 stop primer, 5-CTAGGGCAG-
GGTCACCCGG-3. The truncated mutants of HPS4 shown in
Fig. 2 were produced by PCR using specific primers and full-
length HPS4 cDNA (18) as a template. Mutant HPS4 expression
Figure 8. Re-expression of HPS4(WT or mutants) in melan-le cells and its effect on melanogenesis. A, re-expression of HPS4(WT or mutants) in melan-le
cells and its effect on tyrosinase distribution. Cells stably expressing HPS4(WT, S541A/N543A (SA/NA) or G55W/G59M (GW/GM)) were immunostained with
anti-tyrosinase antibody and then examined with a confocal fluorescence microscope. Corresponding bright-field images are shown on the right. Note that the
tyrosinase signals in control melan-le cells and HPS4(GW/GM)-expressing cells (outlined with a broken line) were clustered in the perinuclear region (arrows)
and that hardly any black mature melanosomes were observed. By contrast, HPS4(WT or SA/NA)-expressing cells contained peripherally distributed tyrosinase
and black, mature melanosomes. Scale bars  20 m. B, tyrosinase expression in HPS4(WT and mutants)-expressing melan-le cells as revealed by immuno-
blotting. Cell lysates were subjected to 10% SDS-PAGE, followed by immunoblotting with anti-HA tag antibody, anti--actin antibody, and anti-tyrosinase
antibody. C, quantification of the level of tyrosinase expression shown in B. The error bars represent the means and S.D. of data from triplicate experiments. **,
p  0.01; NS, not significant. Note that the tyrosinase expression level was significantly increased in HPS4(WT or SA/NA)-expressing melan-le cells. D and E,
increased melanin content in HPS4(WT or SA/NA)-expressing melan-le cells compared with control melan-le cells and HPS4(GW/GM)-expressing cells. Melan-le
cells stably expressing HPS4(WT or mutants) were harvested, and their melanin content was assayed by measuring optical density at 490 nm. The error bars
represent the means and S.D. of data from triplicate experiments. **, p  0.01; *, p  0.05.
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plasmids carrying a His-to-Ala mutation at amino acid position
154 and a Phe-to-Ala mutation at amino acid position 157
(H154A/F157A), Q181A/Q184A, S541A/N543A, H548A/
T552A, or G55W/G59M (Figs. 3 and 5) were also produced by
two-step PCR techniques, essentially as described previously
(32, 45). Sequence information for the primers used in this
study is available from the authors upon request. The purified
PCR products were subcloned into the pGEM-T Easy vector
(Promega, Madison, WI). The HPS4 cDNA inserts were excised
from the vector with appropriate restriction enzymes and sub-
cloned into the pEF-T7/FLAG tag mammalian expression vec-
tors (46), pAct2 yeast expression vector (Clontech/Takara Bio)
and/or the pMRX-IRES-HA tag retrovirus vector (47) as
described previously. The pHPS1 vector was obtained from
the pGBDU-C1 yeast expression vector (48) by replacing the
GAL4 sequence with the mouse HPS4 cDNA sequence.
pGBD-C1-Rab(CA/CN) lacking the C-terminal geranylgera-
nylation site (Cys) except pGBD-C1-Rab6D/41Cys and
pGBD-C1-Rab40ALCys were prepared as described previ-
ously (22–24). cDNAs encoding Rab6D(T44N/Q90L)Cys
and Rab40AL(S28N/Q73L)Cys were produced by two-step
PCR techniques using human Rab6D cDNA and Rab40AL
cDNA (49), respectively, as a template and subcloned into
the pGBD-C1 vector (48). The nomenclature of mammalian
Rabs followed in this study is as described in Aizawa and
Fukuda (49). Other expression plasmids, including pEF-T7-
GST-Varp-ANKR1 (RBD32) and pEF-FLAG-Rab9A, were
prepared as described previously (18, 50).
Yeast two-hybrid and tri-hybrid assays
Yeast two-hybrid assays were performed using pGBD-C1-
Rab(CA/CN)Cys and pAct2-HPS4 (WT or mutants) or
pAct2-HPS1 as described previously (51). The yeast strain,
medium, culture conditions, and transformation protocol used
were also as described previously (48, 51). Yeast tri-hybrid
assays were performed using pGBD-C1-Rab7/32/38(CA/
CN)Cys, pAct2-HPS4 (WT or mutants), and pHPS1. Syn-
thetic complete (SC) medium lacking adenine, histidine, leu-
cine, and tryptophan and SC lacking adenine, histidine, leucine,
tryptophan, and uracil were used as selection media for two-
hybrid assays and tri-hybrid assays, respectively. Yeast cells on
the selection medium were incubated at 30 °C for around 1
week.
Cell cultures, transfections, and stable expression of HPS4
The black mouse– derived immortal melanocyte cell line
melan-a and the light ear mouse– derived immortal melanocyte
cell line melan-le were obtained from the Wellcome Trust
Functional Genomics Cell Bank and cultured as described pre-
viously (31, 33, 52). COS7 cells and Plat-E cells (a kind gift from
Dr. Toshio Kitamura) were maintained at 37 °C under 5% CO2
in DMEM (Fujifilm Wako Pure Chemical, Osaka, Japan) con-
taining 10% fetal bovine serum and antibiotics. Retrovirus pro-
duction and infection were performed essentially as described
previously (53). Stable melan-le cell lines were obtained by
puromycin selection (1.5 g/ml for 2–3 days). Cells were trans-
fected with plasmid DNAs and siRNAs using Lipofectamine
2000 and RNAiMAX (Thermo Fisher Scientific), respectively,
according to the manufacturer’s instructions.
Co-immunoprecipitation assays in COS-7 cells and active-
Rab32 pulldown assays in melanocytes
COS-7 cells were co-transfected for 24 h with pEF-T7-HPS4
(WT or mutants) and pEF-FLAG-HPS1 or pEF-FLAG-Rab9A
using Lipofectamine 2000. The transfected cells were lysed with
lysis buffer (50 mM HEPES-KOH (pH 7.2), 150 mM NaCl, 1 mM
MgCl2, and 1% Triton X-100 supplemented with complete
EDTA-free protease inhibitor mixture (Roche)), and the cell
lysates were incubated for 1 h at 4 °C with anti-FLAG tag
antibody– conjugated agarose beads (Sigma-Aldrich). The
beads were washed three times with washing buffer (50 mM
HEPES-KOH (pH 7.2), 150 mM NaCl, 1 mM MgCl2, and 0.1%
Triton X-100), and proteins bound to the beads were analyzed
by 10% SDS-PAGE followed by immunoblotting with the
appropriate antibodies, as indicated in each figure. Immunore-
active bands were visualized by enhanced chemiluminescence.
COS-7 cell extracts that had been transfected with pEF-T7-
GST-RBD32 (18) were lysed with lysis buffer and allowed to
react with GSH-Sepharose beads for 1 h at 4 °C. The beads were
washed three times with washing buffer and then incubated for
1 h at 4 °C with lysates from melan-le cells stably expressing
HPS4 (WT or mutants) or not expressing HPS4 at all, Rab9A-
knockdown melan-a cells, or control melan-a cells. The pro-
teins bound to the beads were analyzed by 10% SDS-PAGE
followed by immunoblotting with the antibodies indicated in
each figure.
Immunocytochemistry
Immunostaining was performed essentially as described pre-
viously (18, 52). In brief, cultured cells were fixed with 4% para-
formaldehyde or 10% TCA and stained with specific antibodies
against tyrosinase and Rab32. The stained cells were examined
for fluorescence with a confocal fluorescence microscope (Flu-
oview 1000-D; Olympus, Tokyo, Japan) through an objective
lens (	60 magnification, numerical aperture 1.40, Olympus)
and with Fluoview software (version 4.1a, Olympus). The fluo-
rescence signals of Rab32 were captured at random (40 and 63
cells each in Figs. 6A and 7A, respectively) with the confocal
microscope and quantified with ImageJ software (version 1.52i,
National Institutes of Health).
Melanin assays
Melanin assays were performed essentially as described pre-
viously (15, 23). In brief, melanocytes were solubilized in lysis
buffer, the pigment was pelleted by centrifugation at 17,400 	 g
for 10 min at 4 °C, and the pellet was dissolved in 1 M NaOH/
10% DMSO for 30 min at 100 °C. Melanin content was mea-
sured as optical density at 490 nm with a microplate reader
(model 680XR, Bio-Rad) and normalized to total protein
content.
Sequence analysis
The amino acid sequences of various species of HPS4 were
aligned using ClustalW multiple alignment programs (54) pro-
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vided by DNA Data Bank of Japan (DDBJ) (https://www.ddbj.nig.
ac.jp/).5
Statistical analysis
Statistical tests were performed using Tukey’s test or Dun-
nett’s test, and p  0.05 was considered statistically significant.
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melanogenesis, but its Rab9 activity is dispensable for melanogenesis
The BLOC-3 subunit HPS4 is required for activation of Rab32/38 GTPases in
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